ALBIREO PHARMA, INC. Annual Income Tax Expense (Benefit) in USD from 2010 to 2018

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Albireo Pharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2018.
  • Albireo Pharma, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $0.000, a 100% decline year-over-year.
  • Albireo Pharma, Inc. annual Income Tax Expense (Benefit) for 2018 was $20K, a 90.6% decline from 2017.
  • Albireo Pharma, Inc. annual Income Tax Expense (Benefit) for 2017 was $212K, a 242% increase from 2016.
  • Albireo Pharma, Inc. annual Income Tax Expense (Benefit) for 2016 was $62K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2018 $20K -$192K -90.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 $212K +$150K +242% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 $62K +$62K Jan 1, 2016 Dec 31, 2016 10-K 2018-03-27
2015 $0 -$26K -100% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-27
2014 $26K +$11K +73.3% Oct 1, 2013 Sep 30, 2014 10-K 2015-12-22
2013 $15K -$3K -16.7% Oct 1, 2012 Sep 30, 2013 10-K 2014-12-19
2012 $18K -$23K -56.1% Oct 1, 2011 Sep 30, 2012 10-K 2013-12-20
2011 $41K +$145K Oct 1, 2010 Sep 30, 2011 10-K 2013-12-20
2010 -$104K Oct 1, 2009 Sep 30, 2010 10-K 2012-12-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.